Tci Wealth Advisors, Inc. Moderna, Inc. Transaction History

Tci Wealth Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$135.66 - $197.02 $8,817 - $12,806	65 Added 16.13%	468 $71,000
Q4 2022 Feb 06, 2023	BUY	$118.38 - $210.04 $20,361 - $36,126	172 Added 74.46%	403 $72,000
Q3 2022 Nov 08, 2022	BUY	$118.07 - $194.18 $1,180 - $1,941	10 Added 4.52%	231 $27,000
Q2 2022 Jul 19, 2022	SELL	$117.13 - $176.59 $15,695 - $23,663	-134 Reduced 37.75%	221 $32,000
Q1 2022 Apr 29, 2022	SELL	$126.46 - $235.05 $32,373 - $60,172	-256 Reduced 41.9%	355 $61,000
Q4 2021 Jan 24, 2022	BUY	$225.82 - $368.51 $45,841 - $74,807	203 Added 49.75%	611 $155,000
Q3 2021 Oct 29, 2021	BUY	$221.9 - $484.47 $19,971 - $43,602	90 Added 28.3%	408 $157,000
Q2 2021 Aug 02, 2021	BUY	$129.91 - $234.98 $3,767 - $6,814	29 Added 10.03%	318 $75,000
Q1 2021 Apr 29, 2021	BUY	$109.18 - $185.98 $1,419 - $2,417	13 Added 4.71%	289 $38,000
Q2 2020 Jul 20, 2020	BUY	$29.67 - $80.0 $652 - $1,760	22 Added 8.66%	276 $18,000
Q1 2020 Apr 14, 2020	BUY	$17.78 - $31.58 $2,809 - $4,989	158 Added 164.58%	254 $8,000
Q4 2019 Jan 27, 2020	BUY	$13.93 - $21.28 $1,337 - $2,042	96 New	96 $2,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.